T. Rowe Price Associates »

Atyr Pharma shares owned by T. Rowe Price Associates

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by T. Rowe Price Associates from 13F filings

Historical chart of T. Rowe Price Associates investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by T. Rowe Price Associates

Quarter filed Position value Share count Share price at filing
2026-03-31 $36k 46k 0.78
2025-12-31 $36k 46k 0.78
2025-09-30 $34k 46k 0.74
2025-06-30 $221k 44k 5.08
2021-09-30 $109k 12k 9.07

More positions owned by T. Rowe Price Associates

Nvidia Corporation Comm Stk (NVDA)
Apple Comm Stk (AAPL)
Microsoft Corp Comm Stk (MSFT)
Broadcom Comm Stk (AVGO)
Amazon Comm Stk (AMZN)
Alphabet Comm Stk (GOOGL)
Alphabet Comm Stk (GOOG)
Meta Platforms Comm Stk (META)
Eli Lilly & Co Comm Stk (LLY)
Visa Comm Stk (V)
Netflix Comm Stk (NFLX)
Mastercard Incorporated Comm Stk (MA)
Tesla Comm Stk (TSLA)
Jpmorgan Chase & Co Comm Stk (JPM)
Ge Aerospace Comm Stk (GE)

View all positions for T. Rowe Price Associates

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
UBS Group
Vanguard Capital Management
Geode Capital Management
State Street Corporation
GSA Capital Partners
Millennium Management
Morgan Stanley
Two Sigma Investments
Susquehanna International
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management

View all funds holding Atyr Pharma